Plasma concentrations of CRP in group 1 and group 2 at entry and after one month follow up
| Group 1 | Group 2 | ||
|---|---|---|---|
| CRP at entry (mg/l) | CRP after 1 month (mg/l) | CRP at entry (mg/l) | CRP after 1 month (mg/l) |
| Group 1 includes patients treated with irbesartan; group 2 includes patients treated with placebo on top of standard anti-ischaemic therapy. | |||
| 11.36 | 5.2 | 1.57 | 1.82 |
| 2.02 | 0.32 | 2.48 | 2.99 |
| 1.08 | 0.2 | 2.51 | 0.99 |
| 17.7 | 0.4 | 2.31 | 2.25 |
| 4.28 | 0.16 | 21.97 | 4.09 |
| 4.79 | 0.94 | 1.48 | 1.12 |
| 1.39 | 0.99 | 7.6 | 3.02 |
| 0.89 | 1.29 | 1.1 | 3.5 |
| 8.93 | 1.83 | 10.31 | 1.07 |
| 0.7 | 2.44 | 2.5 | 2.25 |
| 9.21 | 1.29 | 1.5 | 1.2 |
| 3.99 | 1.11 | 3.5 | 2.9 |
| 1.57 | 1.38 | ||